Low-dose fortnightly methotrexate in advanced prostate cancer. The EORTC Genito-Urinary Tract Cancer Cooperative Group

Eur J Cancer. 1990;26(5):646. doi: 10.1016/0277-5379(90)90099-f.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Drug Evaluation
  • Humans
  • Male
  • Methotrexate / therapeutic use*
  • Middle Aged
  • Prostatic Neoplasms / drug therapy*

Substances

  • Methotrexate